Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maltitol SCHEMBL3708375 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL18744689 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL7149629 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL13024834 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL18744690 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL13912565 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947405 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947406 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL22516409 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL16153886 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987216-B2 | Polysulfated glycosides and salts thereof | Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) | 2015-03-24 | — | — | US | disclosed |
| US-8987216-B2 | Polysulfated glycosides and salts thereof | Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) | 2015-03-24 | — | — | US | disclosed |
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2011-05-19 | — | — | US | disclosed |
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2011-05-19 | — | — | US | disclosed |
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| US-7902158-B2 | Polysulfated glycosides and salts thereof | Ivax Drug Research Ltd. (HU) | 2011-03-08 | — | — | US | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
| EP-0649427-B1 | SEQUENTIAL REMOVAL OF MONOSACCHARIDES FROM THE REDUCING END OF OLIGOSACCHARIDES AND USES THEREOF | BIOMEMBRANE INST (US) | 1998-01-28 | — | — | EP | disclosed |
| EP-0649427-A1 | SEQUENTIAL REMOVAL OF MONOSACCHARIDES FROM THE REDUCING END OF OLIGOSACCHARIDES AND USES THEREOF | The Biomembrane Institute (US) | 1995-04-26 | — | — | EP | disclosed |
| US-5403927-A | Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof | THE BIOMEMBRANE INSTITUTE (US) | 1995-04-04 | — | — | US | disclosed |
| WO-1993024503-A1 | SEQUENTIAL REMOVAL OF MONOSACCHARIDES FROM THE REDUCING END OF OLIGOSACCHARIDES AND USES THEREOF | THE BIOMEMBRANE INSTITUTE (US) | 1993-12-09 | — | — | WO | disclosed |
| US-4024290-A | GLUCOSE, SORBITOL | G. D. SEARLE & CO. (US) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | CFTR, AREG, STS | L3MBTL1 3761/4885PPARG 1548/4885PPARD 2750/4885 |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | L3MBTL1 3761/4885PPARG 1548/4885PPARD 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.